Variables | Total | Men | Women | p-value |
---|---|---|---|---|
n (%) | 226 | 139 (61.50) | 87 (38.50) | n/a |
Age (median [IQR]) | 72 [66–78] | 70 [65–77] | 77 [69–80] | 0.000 |
BS, cm2 (mean ± SD) | 1.81 ± 0.20 | 1.90 ± 0.16 | 1.67 ± 0.16 | 0.000 |
HTA, n (%) | 156 (69.0) | 97 (69.8) | 59 (67.8) | 0.756 |
Renal insuficiency, n (%) | 14 (6.2) | 7 (5) | 7 (8) | 0.361 |
Creatinine (mg/dL) | 0.86 [0.76–1.01] | 0.91 [0.81–1.1] | 0.79 [0.70–0.94] | 0.000 |
NYHA class, n (%) | ||||
I | 24 (10.6) | 19 (13.7) | 5 (5.7) | 0.076 |
II | 137 (60.6) | 91 (65.5) | 46 (52.9) | 0.069 |
III | 61 (27.0) | 28 (20.1) | 33 (37.9) | 0.005 |
IV | 4 (1.8) | 1 (0.7) | 3 (3.4) | 0.160 |
Mean gradient (mmHg) | 50.2 (13.6) | 49.7 (13.6) | 50.9 (13.7) | 0.559 |
Max gradient (mmHg) | 78.8 (19.6) | 78.6 (19.7) | 79.1 (19.7) | 0.879 |
Drug medicines | ||||
ACEi, n (%) | 58 (25.7) | 36 (25.9) | 22 (25.3) | 0.918 |
ARB, n (%) | 54 (23.9) | 34 (24.5) | 20 (23) | 0.801 |
Diuretics, n (%) | 122 (54) | 67 (48.2) | 55 (63.2) | 0.026 |
β-blockers, n (%) | 65 (28.8) | 41 (23.5) | 24 (27.6) | 0.758 |
Statins, n (%) | 141 (62.4) | 100 (71.9) | 41 (47.1) | 0.000 |